Literature DB >> 16876497

Autologous serum for the treatment of corneal epithelial abrasions in diabetic patients undergoing vitrectomy.

Stephan D Schulze1, Walter Sekundo, Peter Kroll.   

Abstract

PURPOSE: To compare the effect of autologous serum versus hyaluronic acid for the treatment of epithelial corneal lesions in patients such as diabetics with reduced wound healing.
DESIGN: Prospective, randomized, masked clinical trial.
METHODS: Diabetic patients undergoing pars plana vitrectomy mostly combined with cataract extraction and intraocular lens (IOL) implantation who received corneal abrasion for better intraoperative visualization were included in this study. A standardized 8-mm diameter corneal abrasion was performed. Patients were randomized into one group treated with hourly application of autologous serum and another treated with hyaluronic acid drops (Vislube). Besides the time necessary for closure of the corneal epithelium other parameters such as patients' age, gender, duration of surgery, history of diabetes, and current HbA1C were evaluated.
RESULTS: A total of 23 patients were enrolled (15 men, eight women); the autologous serum group consisted of 13 patients, the hyaluronic acid (Vislube) group consisted of 10 patients. Patients' mean age was 64.8 years; mean duration of diabetes was 19.4 years. On average, the operation lasted 145 minutes. Mean epithelialization time was 7.1 days in the hyaluronic acid group. In the autologous serum group, epithelium healed after a mean of 4.3 days. Mann-Whitney U test for statistical analysis showed a significant difference of epithelial closure time between both groups (P < .05); therefore, the study was stopped after treatment of 23 patients.
CONCLUSIONS: It appears that autologous serum leads to a much faster closure of corneal epithelial wounds after abrasion compared with artificial tears.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16876497     DOI: 10.1016/j.ajo.2006.04.017

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  27 in total

Review 1.  Diabetic complications in the cornea.

Authors:  Alexander V Ljubimov
Journal:  Vision Res       Date:  2017-04-28       Impact factor: 1.886

Review 2.  [Albumin eye drops for treatment of ocular surface diseases].

Authors:  J D Unterlauft; M Kohlhaas; I Hofbauer; K Kasper; G Geerling
Journal:  Ophthalmologe       Date:  2009-10       Impact factor: 1.059

3.  Serum eye drops for the treatment of ocular surface diseases: a systematic review and meta-analysis.

Authors:  Massimo Franchini; Mario Cruciani; Carlo Mengoli; Giuseppe Marano; Enrico Capuzzo; Ilaria Pati; Francesca Masiello; Eva Veropalumbo; Simonetta Pupella; Stefania Vaglio; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2019-05       Impact factor: 3.443

4.  Sensory nerve regeneration after epithelium wounding in normal and diabetic cornea.

Authors:  Fu-Shin Yu; Jia Yin; Patrick Lee; Frank S Hwang; Mark McDermott
Journal:  Expert Rev Ophthalmol       Date:  2015-06-26

5.  Advanced glycation end products delay corneal epithelial wound healing through reactive oxygen species generation.

Authors:  Long Shi; Hongmei Chen; Xiaoming Yu; Xinyi Wu
Journal:  Mol Cell Biochem       Date:  2013-08-18       Impact factor: 3.396

6.  Application of autologous serum eye drops after pterygium surgery: a prospective study.

Authors:  Sabahattin Sul; Safak Korkmaz; Goksu Alacamli; Pelin Ozyol; Erhan Ozyol
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-07-18       Impact factor: 3.117

7.  Corneal complications in streptozocin-induced type I diabetic rats.

Authors:  Jia Yin; Jenny Huang; Cynthia Chen; Nan Gao; Feng Wang; Fu-Shin X Yu
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-22       Impact factor: 4.799

8.  Bioluminescence Imaging of Matrix Metalloproteinases-2 and -9 Activities in Ethanol-injured Cornea of Mice.

Authors:  Seung-Bo Park; Seung Hyo Jung; Hengzhe Jin; Su Jung Kim; Yunkyoung Ryu; Kyung-Jin Lee; Bokyung Kim; Hyun Jin Shin; Kyung-Jong Won
Journal:  In Vivo       Date:  2021 May-Jun       Impact factor: 2.155

9.  Naltrexone and insulin are independently effective but not additive in accelerating corneal epithelial healing in type I diabetic rats.

Authors:  Matthew S Klocek; Joseph W Sassani; Patricia J McLaughlin; Ian S Zagon
Journal:  Exp Eye Res       Date:  2009-07-01       Impact factor: 3.467

10.  Topical application of naltrexone facilitates reepithelialization of the cornea in diabetic rabbits.

Authors:  I S Zagon; Joseph W Sassani; Melissa A Carroll; Patricia J McLaughlin
Journal:  Brain Res Bull       Date:  2009-10-21       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.